KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 159 filers reported holding KITE PHARMA INC in Q2 2015. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $395,000 | -64.5% | 2,198 | -79.5% | 0.00% | -75.0% |
Q2 2017 | $1,113,000 | +33.0% | 10,736 | +0.3% | 0.00% | -33.3% |
Q1 2017 | $837,000 | +78.5% | 10,700 | +4.8% | 0.01% | +50.0% |
Q4 2016 | $469,000 | -18.6% | 10,210 | -2.8% | 0.00% | -20.0% |
Q3 2016 | $576,000 | -1.0% | 10,506 | -7.1% | 0.01% | 0.0% |
Q2 2016 | $582,000 | -54.9% | 11,307 | -56.1% | 0.01% | +25.0% |
Q1 2016 | $1,290,000 | -9.6% | 25,776 | +12.6% | 0.00% | 0.0% |
Q4 2015 | $1,427,000 | +81.6% | 22,898 | +80.6% | 0.00% | 0.0% |
Q3 2015 | $786,000 | -20.1% | 12,678 | -15.9% | 0.00% | -20.0% |
Q2 2015 | $984,000 | +24.1% | 15,067 | +5.7% | 0.01% | +25.0% |
Q1 2015 | $793,000 | – | 14,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|